SOTERA HEALTH COMPANY Increase (Decrease) in Other Current Assets
SOTERA HEALTH COMPANY (SHC) reported Increase (Decrease) in Other Current Assets of $8.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-06
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for the quarter ending 2026-06-30 was $5.72M, a 45.79% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for the quarter ending 2026-03-31 was $3.00M, a 18.85% decline year-over-year.
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$6.05M.
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for the quarter ending 2025-09-30 was $4.70M.
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for fiscal 2025 was $12.90M.
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for fiscal 2024 was -$3.60M.
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for fiscal 2023 was -$4.00M, a 168.83% decline from fiscal 2022.
- SOTERA HEALTH COMPANY increase (decrease) in other current assets for fiscal 2022 was $5.82M, a 63.74% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.72M 10-Q · filed 2026-08-06 | $2.67M derived: sum of 3 quarters · filed 2026-08-06 | $7.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.00M 10-Q · filed 2026-05-05 | -$3.05M derived: sum of 2 quarters · filed 2026-05-05 | $1.65M derived: sum of 3 quarters · filed 2026-05-05 | $12.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.35M derived: sum of 2 quarters · filed 2026-02-24 | $9.21M derived: sum of 3 quarters · filed 2026-08-06 | $12.90M 10-K · filed 2026-02-24 |
| 2025-09-30 | $4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $15.26M derived: sum of 2 quarters · filed 2026-08-06 | $18.95M 10-Q · filed 2025-11-04 | $12.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $10.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $14.25M 10-Q · filed 2026-08-06 | $7.36M derived: sum of 3 quarters · filed 2026-08-06 | $7.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.69M 10-Q · filed 2026-05-05 | -$3.20M derived: sum of 2 quarters · filed 2026-05-05 | -$3.51M derived: sum of 3 quarters · filed 2026-05-05 | -$155.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$6.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$7.20M derived: sum of 2 quarters · filed 2026-02-24 | -$3.85M derived: sum of 3 quarters · filed 2026-02-24 | -$3.60M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.04M derived: sum of 2 quarters · filed 2025-11-04 | $3.29M 10-Q · filed 2025-11-04 | -$1.60M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $3.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $3.60M 10-Q · filed 2025-08-08 | -$1.29M derived: sum of 3 quarters · filed 2026-02-24 | -$9.62M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $250.00K 10-Q · filed 2025-05-01 | -$4.64M derived: sum of 2 quarters · filed 2026-02-24 | -$12.97M derived: sum of 3 quarters · filed 2026-02-24 | -$10.07M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$13.22M derived: sum of 2 quarters · filed 2026-02-24 | -$10.32M derived: sum of 3 quarters · filed 2026-02-24 | -$4.00M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$8.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$5.43M derived: sum of 2 quarters · filed 2024-11-05 | $892.00K 10-Q · filed 2024-11-05 | -$6.36M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $9.22M 10-Q · filed 2024-08-05 | $1.97M derived: sum of 3 quarters · filed 2025-02-27 | $8.35M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $6.32M 10-Q · filed 2024-05-02 | -$932.00K derived: sum of 2 quarters · filed 2025-02-27 | $5.45M derived: sum of 3 quarters · filed 2025-02-27 | $3.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$7.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$867.00K derived: sum of 2 quarters · filed 2025-02-27 | -$3.12M derived: sum of 3 quarters · filed 2025-02-27 | $5.82M 10-K · filed 2025-02-27 |
| 2022-09-30 | $6.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $4.13M derived: sum of 2 quarters · filed 2023-11-01 | $13.07M 10-Q · filed 2023-11-01 | $18.84M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $6.68M 10-Q · filed 2023-08-03 | $12.46M derived: sum of 3 quarters · filed 2024-02-27 | $11.22M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $8.93M 10-Q · filed 2023-05-03 | $14.71M derived: sum of 2 quarters · filed 2024-02-27 | $13.47M derived: sum of 3 quarters · filed 2024-02-27 | $10.16M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.54M derived: sum of 2 quarters · filed 2024-02-27 | $1.23M derived: sum of 3 quarters · filed 2024-02-27 | $3.55M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$4.55M derived: sum of 2 quarters · filed 2022-11-02 | -$2.23M 10-Q · filed 2022-11-02 | $2.85M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$983.00K 10-Q · filed 2022-08-04 | $4.09M derived: sum of 3 quarters · filed 2023-02-28 | $5.83M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $2.32M 10-Q · filed 2022-05-05 | $7.40M derived: sum of 2 quarters · filed 2023-02-28 | $9.14M derived: sum of 3 quarters · filed 2023-02-28 | $8.69M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.81M derived: sum of 2 quarters · filed 2023-02-28 | $6.37M derived: sum of 3 quarters · filed 2023-02-28 | $7.77M 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.29M derived: sum of 2 quarters · filed 2021-11-10 | $2.70M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$447.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $957.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $1.40M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | -$15.32M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |